WAVEMAN · COMPANY

REX · Rex American Resources Corp

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

REX

Name: REX AMERICAN RESOURCES Corp (REX) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

REX AMERICAN RESOURCES Corp

PHARMA & BIOTECH · INDUSTRIAL ORGANIC CHEMICALS · CIK 0000744187

SEC FILINGS☆ WATCH

INSIDER NET · 180D

-$5.0M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

117

13F, latest reported quarter

REVENUE GROWTH

+1.2%

XBRL, annual

NET MARGIN

14.6%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$5.0M over 180 days

-$4.4M over 90 days

below 78% of Pharma & Biotech

CONGRESS

no member of Congress has reported trading it

FUNDS

117 funds added or opened last quarter

more than 71% of Pharma & Biotech

REVENUE

+1.2% year over year

below 52% of Pharma & Biotech

MARGIN

14.6% net margin

more than 85% of Pharma & Biotech

BUYBACKS

$33.4M repurchased, FY to 2026-01-31

below 51% of Pharma & Biotech

SHORT

no short interest reported

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

117 funds added or opened positions in the latest 13F quarter, of 232 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +36.5%

+36.5%12M

INSIDER SELL

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows a net $5.0M sold by insiders over 180 days, 117 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, REX AMERICAN RESOURCES Corp insiders sold a net $5.0M of stock across 158 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

ROSE STUART A

Executive COB

SELL

2026-06-18

15,186.0

$662.7K

ROSE STUART A

Executive COB

SELL

2026-06-17

69,335.0

$3.0M

ROSE STUART A

Executive COB

SELL

2026-06-11

766.0

$33.8K

ROSE STUART A

Executive COB

SELL

2026-06-10

1,129.0

$50.3K

ROSE STUART A

Executive COB

SELL

2026-06-08

13,584.0

$614.4K

158 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 153 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

5,662,010.0 sh

$255.6M

DIMENSIONAL FUND ADVISORS LP

1,825,770.0 sh

$82.4M

STATE STREET CORP

1,573,545.0 sh

$71.0M

RENAISSANCE TECHNOLOGIES LLC

1,458,366.0 sh

$65.8M

VANGUARD PORTFOLIO MANAGEMENT LLC

1,284,806.0 sh

$58.0M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Invesco WilderHill Clean Energy ETF

$6.8M POSITION · AS OF 2026-04-30

1.5%

ALPS Clean Energy ETF

$1.5M POSITION · AS OF 2026-02-28

1.3%

Transamerica Small Cap Value

$1.3M POSITION · AS OF 2026-04-30

1.2%

Invesco S&P SmallCap Energy ETF

$1.2M POSITION · AS OF 2026-02-28

1.2%

Brown Advisory Small-Cap Fundamental Value Fund

$12.5M POSITION · AS OF 2026-03-31

1.2%

JAMES MICRO CAP FUND

$329.0K POSITION · AS OF 2026-03-31

1.1%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Executive pay vs shareholder return · Mr. Rizvi

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2023

$6.1M

$7.0M

$2.9M

+65%

+71%

2022

$4.0M

$4.6M

$1.7M

+30%

+189%

2021

$2.2M

$1.7M

$1.5M

+28%

+176%

2020

$359.2K

$397.3K

$297.8K

+2%

+122%

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2026-01	2025-01	2024-01	2023-01
REVENUE	$650.5M	$642.5M	$833.4M	$855.0M
GROSS PROFIT	$125.4M	$91.5M	$98.2M	$48.6M
NET INCOME	$83.0M	$58.2M	$60.9M	$27.7M
EPS (DILUTED)	2.50	1.65	1.73	1.57
OPERATING CASH FLOW	$117.8M	$64.2M	$128.0M	$54.8M
CASH	$188.7M	$196.3M	$223.4M	$69.6M
BUYBACKS	$33.4M	$14.7M	$0	$13.0M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE